CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 290 enrolled
Drug / intervention
Not applicable / dataset analysisother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03973905
NCT03973905N/ACompleted

Effectiveness of Maternal Immunization With Boostrix at Preventing Pertussis Among Infants <2 Months Old in the United States: Analysis of a Dataset From a Case-control Study

GlaxoSmithKline·observational·Posted Jun 4, 2019·Updated Jul 7, 2020

In Brief

An observational study evaluating Not applicable / dataset analysis for Whooping Cough. Completed, enrolled 290 participants across 1 site.

Detailed Summary

The purpose of this study is to estimate the effectiveness of maternal immunization with Boostrix at preventing pertussis in infants in the United States.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsWhooping Cough
CountriesBelgium
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 4, 2019
Enrollment StartFeb 15, 2019
Primary CompletionMay 15, 2019
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 7.1 years ago

Interventions

Not applicable / dataset analysisother

Not applicable / dataset analysis